Advanced Biomed Inc. (ADVB)
NASDAQ: ADVB · Real-Time Price · USD
4.950
+0.490 (10.99%)
At close: Mar 9, 2026, 4:00 PM EDT
4.870
-0.080 (-1.62%)
After-hours: Mar 9, 2026, 7:40 PM EDT
Advanced Biomed Cash Flow Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
| TTM
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| Net Income | 4.39 | -3.26 | -2.78 | -3.73 | -4.03 | -1.84 |
| Depreciation & Amortization | 0.33 | 0.34 | 0.4 | 0.23 | 0.11 | 0.06 |
| Other Amortization | - | - | - | 0.14 | 0.01 | - |
| Loss (Gain) From Sale of Assets | -7.35 | - | - | 0.15 | 0.04 | - |
| Asset Writedown & Restructuring Costs | - | - | - | - | 1.62 | - |
| Change in Accounts Payable | -0.49 | -0.12 | 0.48 | 0.38 | 0.91 | 0.02 |
| Change in Other Net Operating Assets | -2.14 | -2.79 | -0.22 | -0.13 | 0.59 | 1.29 |
| Operating Cash Flow | -6.08 | -5.83 | -2.13 | -2.96 | -0.74 | -0.47 |
| Capital Expenditures | -0.04 | -0.03 | -0.07 | -0.21 | -0.89 | -0.03 |
| Sale of Property, Plant & Equipment | - | - | - | - | 0.03 | - |
| Cash Acquisitions | - | - | - | - | 0.2 | - |
| Divestitures | - | - | - | -0.05 | - | - |
| Sale (Purchase) of Intangibles | - | - | - | -0 | -0.42 | - |
| Investing Cash Flow | -0.04 | -0.03 | -0.07 | -0.26 | -1.08 | -0.03 |
| Short-Term Debt Issued | - | 0.3 | 0.29 | - | - | - |
| Long-Term Debt Issued | - | 0.98 | 1.66 | - | - | - |
| Total Debt Issued | 0.91 | 1.28 | 1.95 | - | - | - |
| Short-Term Debt Repaid | - | -0.24 | - | - | - | - |
| Long-Term Debt Repaid | - | -0.6 | - | - | - | - |
| Total Debt Repaid | -0.85 | -0.84 | - | - | - | - |
| Net Debt Issued (Repaid) | 0.06 | 0.44 | 1.95 | - | - | - |
| Issuance of Common Stock | 5.49 | 5.49 | - | 1.01 | 6.1 | 0.7 |
| Other Financing Activities | 0.35 | - | -0.09 | -0.55 | - | - |
| Financing Cash Flow | 5.9 | 5.93 | 1.87 | 0.46 | 6.1 | 0.7 |
| Foreign Exchange Rate Adjustments | 0.17 | 0.22 | 0.32 | 0.61 | 0.45 | -0.2 |
| Net Cash Flow | -0.05 | 0.3 | -0.01 | -2.16 | 4.72 | 0 |
| Free Cash Flow | -6.11 | -5.86 | -2.2 | -3.17 | -1.63 | -0.5 |
| Free Cash Flow Per Share | -5.73 | -5.71 | -2.20 | -3.19 | -2.30 | -0.87 |
| Levered Free Cash Flow | -10.74 | -4.38 | -2.72 | -1.4 | 0.69 | - |
| Unlevered Free Cash Flow | -10.74 | -4.38 | -2.72 | -1.4 | 0.69 | - |
| Change in Working Capital | -2.63 | -2.91 | 0.26 | 0.25 | 1.5 | 1.31 |
Source: S&P Capital IQ. Standard template.
Financial Sources.